Julie A. Vetalice, Author at ORTHOWORLD

Lima Corporate Expands Shoulder Portfolio, Marks 15 Years with Modular Shoulder

Lima Corporate marked the 15th anniversary of its SMR modular shoulder system with launch of SMR bone graft instruments and Lima Personalized Surgical Instruments.

May 16, 2017

Orthonika Secures Funding to Support Synthetic Meniscus Replacement

Investments The Numbers

Orthonika closed a £0.7MM (~US $0.91MM) investment round. Funds will support biomechanical testing and a preclinical pilot trial of MenisciKnit™, a novel synthetic total knee meniscus replacement.

May 15, 2017

Exactech Receives FDA Clearance for ExactechGPS Shoulder Application

ORTHOFLASH Robotics/Tech

Exactech received FDA 510(k) clearance to market the ExactechGPS® Shoulder Application. Initial U.S. launch is slated for 2Q17.

May 15, 2017

DePuy Synthes Awarded US DOD Contract for Orthopaedic Products

Company Updates Competitive Landscape

DePuy Synthes was awarded a contract from the U.S. Department of Defense to supply up to US $260MM worth of orthopaedic products to global U.S. military medical facilities.

May 15, 2017

Episurf Medical Update: US Regulatory Path

Joint Replacement ORTHOFLASH

Episurf Medical commenced internal actions to select its regulatory pathway for application for U.S. market acceptance. A decision is expected by 3Q17.

May 15, 2017

OrthAlign Receives Japan Approval for Direct Anterior HipAlign and UniAlign

Joint Replacement ORTHOFLASH

OrthAlign received Japan regulatory approval to market Direct Anterior HipAlign® for use in supine position THA and UniAlign™ for UKA, to be distributed by Zimmer Biomet Japan.

May 15, 2017

Curasan Launches CERASORB Ortho Foam in the US

Orthobiologics ORTHOFLASH

CURASAN entered the U.S. market with the first U.S. implantation of CERASORB® Ortho Foam bone graft.

May 15, 2017

Vertebral Technologies Granted Patent for Modular Device Design

ORTHOFLASH Spine

Vertebral Technologies received notice of allowance for its patent, "Methods and Apparatus for Minimally Invasive Modular Interbody Fusion Devices."

May 11, 2017

Intrinsic Therapeutics Closes $49MM Financing

Investments The Numbers

Intrinsic Therapeutics closed a US $49MM round of financing, which will support global commercialization of the Barricaid Anular Closure Device.

May 10, 2017

Providence Medical Technology Secures New $10.5MM Financing

Investments The Numbers

Providence Medical Technology closed a US $10.5MM debt agreement that will support distribution of cervical fusion technology in U.S. and ex-U.S. markets.

May 10, 2017

Get the ORTHOWORLD Newsletter!

Contact Us